BillsSS. 5043
A bill to direct the Food and Drug Administration to prevent the importation of counterfeit, unapproved, misbranded, or adulterated drugs from the People's Republic of China or other foreign countries, to establish enhanced safeguards for imported drug products, and for other purposes.
Stage
In committee
Latest action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
July 21, 2026
Committees
- PrimaryHealth, Education, Labor, and Pensions Committee
Action history
- July 21, 2026Introduced in Senate
- July 21, 2026Read twice and referred to the Committee on Health, Education, Labor, and Pensions.